Oncoinvent to present preclinical efficacy data in a poster session at the 20th Biennial Meeting of the European Society of Gynaecological Oncology (ESGO 2017)

The poster ‘Preclinical Evaluation of a Novel Alpha-Particle Emitting Therapeutic Agent for Intraperitoneal Therapy of Peritoneal Metastases’ by Oncoinvent scientists Tina B. Bønsdorff, Sara Westrøm, Øyvind S. Bruland and Roy H. Larsen will be presented at the congress.

Organiser: ESGO
Venue: Austria Center Vienna, Bruno Kreisky Platz 1, Vienna, 1210 Austria
Date: 11.04.2017
Program: Program